Skip to main content Skip to main navigation menu Skip to site footer

Clinical presentation and outcome of COVID-19 infection in Type 2 Diabetes Mellitus: a preliminary data from a tertiary hospital in Jakarta during the early days of the pandemic

  • Ida Ayu Kshanti ,
  • Giri Aji ,
  • Marina Epriliawati ,
  • Md Ikhsan Mokoagow ,
  • Jerry Nasarudin ,
  • Nadya Magfira ,
  • Anggraini Permata Sari ,
  • Annela Manurung ,
  • Aryan Yohanes Djojo ,
  • Elizabeth Yasmine Wardoyo ,
  • Martha Iskandar ,
  • Nikko Darnindro ,
  • Radhiyatam Mardiyah ,


Abstract

Introduction. This study aimed to review the clinical characteristics and outcomes of COVID-19 patients presented with in-hospital hyperglycemia or pre-existing type 2 diabetes (T2DM).

Methods. This is a retrospective study conducted in Fatmawati General Hospital, Indonesia, from March 18th-Apr 30th, 2020. We reviewed medical records of 27 COVID-19 patients presented with either in-hospital hyperglycemia (11, 12.2%) or pre-existing T2DM (16, 17.8%) from a total of 90 confirmed COVID-19 cases admitted in our hospital.

Results. Critical conditions occurred in 50% of T2DM and 54.55% of the in-hospital hyperglycemia group. Mortality was documented in 68.75% of T2DM and 81.82% of in-hospital hyperglycemia group. Hypoglycemia, diabetic ketoacidosis, lactic acidosis and ketosis were found in 12.5%, 25%, 18.75%, and 25% of individuals with T2DM, respectively, resulting in a high mortality rate. Meanwhile, diabetes-related complications were rare among the in-hospital hyperglycemia group. However, respiratory failure (45.45% vs. 6.25%) and septic shock (27.27% vs. 6.25%) were more frequent than in the T2DM group.

Conclusion. In this preliminary study, a high mortality rate was documented among COVID-19 patients with preexisting T2DM and in-hospital hyperglycemia. In T2DM subjects, diabetes related-complications contributed to a higher mortality rate, while in-hospital hyperglycemia group, respiratory failure and septic shock were more frequent.

Keywords: COVID-19 diabetes hyperglycemia outcome Indonesia

References

  1. WHO. Coronavirus Disease 2019 (COVID-19), "Situation Report-51." World Heal Organ. 2020. doi:10.1001/jama.2020.2633
  2. Wu Y, Ho W, Huang Y, et al. SARS-CoV-2 is an appropriate name for the new coronavirus. Lancet. 2020;395(10228):949-950. doi:10.1016/S0140-6736(20)30557-2
  3. Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. BMJ. 2020;368(March):1-14. doi:10.1136/bmj.m1091
  4. WHO. Coronavirus disease (COVID-19), "Situation Report-108." World Heal Organ. 2020;2019(March):2633. doi:10.1001/jama.2020.2633
  5. Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA - J Am Med Assoc. 2020;323(13):1239-1242. doi:10.1001/jama.2020.2648
  6. Li B, Yang J, Zhao F, et al. prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020:531-538. doi:10.1007/s00392-020-01626-9
  7. Bruce Bode MD., , Valerie Garrett, M.D. MPH., , Jordan Messler MD, et al. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States. J Chem Inf Model. 2013;53(9):1689-1699. doi:10.1017/CBO9781107415324.004
  8. Shi Q, Zhang X, Jiang F, et al. Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study. Diabetes Care. 2020:dc200598. doi:10.2337/dc20-0598
  9. IDF. Eighth Edition 2017.; 2017. doi:http://dx.doi. org/10.1016/S0140-6736(16)31679-8.
  10. Care D, Suppl SS. 15. Diabetes care in the hospital: Standards of medical care in diabetesd2019. Diabetes Care. 2019;42(January):S173-S181. doi:10.2337/dc19-S015
  11. Kellum JA, Lameire N, Aspelin P, et al. Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1-138. doi:10.1038/kisup.2012.1
  12. Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Vol 45.; 2017. doi:10.1097/CCM.0000000000002255
  13. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335-1343. doi:10.2337/dc09-9032
  14. Care D, Suppl SS. 6. Glycemic targets: Standards of medical care in diabetesd2019. Diabetes Care. 2019;42(January):S61-S70. doi:10.2337/dc19-S006
  15. Shabto JM, Loerinc L, O'Keefe GA, O'Keefe J. Characteristics and Outcomes of COVID-19 Positive Patients with Diabetes Managed as Outpatients. Diabetes Res Clin Pract. 2020;164:108229. doi:https://doi.org/10.1016/j.diabres.2020.108229
  16. Mao R, Qiu Y, He JS, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;1253(20). doi:10.1016/S2468-1253(20)30126-6
  17. Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis. Eur Respir J. 2020;(March 2020). doi:10.1183/13993003.00547-2020
  18. Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-95. doi:10.1016/j.ijid.2020.03.017
  19. Fatima S, Ratnani I, Husain M, Surani S. Radiological Findings in Patients with COVID-19. Cureus. 2020;12(4):10-14. doi:10.7759/cureus.7651
  20. Zhang Y, Cui Y, Shen M, et al. Association of Diabetes Mellitus with Disease Severity and Prognosis in COVID-19: A Retrospective Cohort Study. Diabetes Res Clin Pract. 2020;165:108227. doi:https://doi.org/10.1016/j.diabres.2020.108227
  21. Yuen Frank Wong H, Yin Sonia Lam H, Ho-Tung Fong A, et al. Frequency and Distribution of Chest Radiographic Findings in COVID-19 Positive Patients Authors. Radiology. 2020.
  22. Li X, Ma X. Acute respiratory failure in COVID-19: is it "typical" ARDS? Crit Care. 2020;24(1):198. doi:10.1186/s13054-020-02911-9
  23. Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract. 2020;162(January):108142. doi:10.1016/j.diabres.2020.108142
  24. Orioli L, Hermans MP, Thissen JP, Maiter D, Vandeleene B, Yombi JC. COVID-19 in diabetic patients: Related risks and specifics of management. Ann Endocrinol (Paris). 2020;81(2-3):101-109. doi:10.1016/j.ando.2020.05.001
  25. Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020;(December 2019):105938. doi:10.1016/j.ijantimicag.2020.105938
  26. Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):1-2. doi:10.5582/BST.2020.01047
  27. Li J, Wang X, Chen J, Zuo X, Zhang H, Deng A. COVID-19 infection may cause ketosis and ketoacidosis. Diabetes, Obes Metab. 2020. doi:10.1111/dom.14057
  28. Iacobellis G, Penaherrera CA, Bermudez LE, Bernal Mizrachi E. Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes. Diabetes Res Clin Pract. 2020;164:108185. doi:10.1016/j.diabres.2020.108185
  29. Ceriello A. Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory. Diabetes Res Clin Pract. 2020;163(January):108186. doi:10.1016/j.diabres.2020.108186
  30. Zhu L, She ZG, Cheng X, et al. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab. 2020:1-10. doi:10.1016/j.cmet.2020.04.021

How to Cite

Kshanti, I. A., Aji, G., Epriliawati, M., Mokoagow, M. I., Nasarudin, J., Magfira, N., Sari, A. P., Manurung, A., Djojo, A. Y., Wardoyo, E. Y., Iskandar, M., Darnindro, N., & Mardiyah, R. (2020). Clinical presentation and outcome of COVID-19 infection in Type 2 Diabetes Mellitus: a preliminary data from a tertiary hospital in Jakarta during the early days of the pandemic. Bali Medical Journal, 9(3), 787–793. https://doi.org/10.15562/bmj.v9i3.1969
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
0

Total
14

Share

Search Panel

Ida Ayu Kshanti
Google Scholar
Pubmed
BMJ Journal

Giri Aji
Google Scholar
Pubmed
BMJ Journal

Marina Epriliawati
Google Scholar
Pubmed
BMJ Journal

Md Ikhsan Mokoagow
Google Scholar
Pubmed
BMJ Journal

Jerry Nasarudin
Google Scholar
Pubmed
BMJ Journal

Nadya Magfira
Google Scholar
Pubmed
BMJ Journal

Anggraini Permata Sari
Google Scholar
Pubmed
BMJ Journal

Annela Manurung
Google Scholar
Pubmed
BMJ Journal

Aryan Yohanes Djojo
Google Scholar
Pubmed
BMJ Journal

Elizabeth Yasmine Wardoyo
Google Scholar
Pubmed
BMJ Journal

Martha Iskandar
Google Scholar
Pubmed
BMJ Journal

Nikko Darnindro
Google Scholar
Pubmed
BMJ Journal

Radhiyatam Mardiyah
Google Scholar
Pubmed
BMJ Journal